Compounds > 1-methyl-3-isobutylxanthine
Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Cochlear Hearing Loss

1-methyl-3-isobutylxanthine has been researched along with Cochlear Hearing Loss in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Navaratnam, DS1
Su, HS1
Scott, SP1
Oberholtzer, JC1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Cochlear Hearing Loss

ArticleYear
Proliferation in the auditory receptor epithelium mediated by a cyclic AMP-dependent signaling pathway.
    Nature medicine, 1996, Volume: 2, Issue:10

    Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Carbazoles; Chickens;

1996